Iida N, Takara K, Ohmoto N, Nakamura T, Kimura T, Wada A, Hirai M, Sakaeda T, Okumura K
Department of Hospital Pharmacy, School of Medicine, Kobe University, Japan.
Biol Pharm Bull. 2001 Sep;24(9):1032-6. doi: 10.1248/bpb.24.1032.
In this study, the antiproliferative effects of vinblastine (VLB), paclitaxel (TXL), doxorubicin (DXR), daunorubicin (DNR) and 5-fluorouracil (5-FU) were assessed in the human cervical carcinoma cell line HeLa-Ohio (HeLa) and Hvr100-6 cells, established by growing the parental HeLa cells in the presence of progressively greater concentrations of VLB in the culture medium. Flow cytometric analysis indicated the induction of MDR1 (P-glycoprotein) in Hvr100-6 cells with no alterations in levels of multidrug resistance-associated protein (MRP). Resistance to VLB, TXL, DXR and DNR was found in Hvr100-6 cells with relative resistances of ca. 300, 4000, 50 and 200, respectively, whereas no resistance was found to 5-FU. The reversal effects of antifungal drugs, fluconazole, itraconazole, ketoconazole, miconazole and amphotericin B on multidrug resistance were also assessed using Hvr100-6 cells. Itraconazole was found to have potent reversal effect on the resistance to VLB and TXL, but the others had no such effect. This reversal effect of itraconazole was concentration-dependent, with dose modifying factors of 3.2, 10.1 and 435.7 at 0.1, 0.25 and 0.5 microM of itraconazole, respectively. In addition, this reversal effect of itraconazole was explained by the inhibition of accumulation of the anticancer drugs.
在本研究中,评估了长春碱(VLB)、紫杉醇(TXL)、阿霉素(DXR)、柔红霉素(DNR)和5-氟尿嘧啶(5-FU)对人子宫颈癌细胞系HeLa-Ohio(HeLa)和Hvr100-6细胞的抗增殖作用,Hvr100-6细胞是通过在培养基中存在逐渐增加浓度的VLB的情况下培养亲代HeLa细胞而建立的。流式细胞术分析表明,Hvr100-6细胞中MDR1(P-糖蛋白)被诱导,而多药耐药相关蛋白(MRP)水平无变化。在Hvr100-6细胞中发现对VLB、TXL、DXR和DNR有耐药性,相对耐药性分别约为300、4000、50和200,而对5-FU未发现耐药性。还使用Hvr100-6细胞评估了抗真菌药物氟康唑、伊曲康唑、酮康唑、咪康唑和两性霉素B对多药耐药的逆转作用。发现伊曲康唑对VLB和TXL的耐药性有强效逆转作用,但其他药物没有这种作用。伊曲康唑的这种逆转作用是浓度依赖性的,在伊曲康唑浓度为0.1、0.25和0.5 microM时,剂量修正因子分别为3.2、10.1和435.7。此外,伊曲康唑的这种逆转作用可以通过抑制抗癌药物的积累来解释。